Evidence map›Paper›PMID 40530649›Full record

GuidelineRevista espanola de salud publica2025

[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions].

Mónica Povedano Pandés, Ricard Rojas García, Luis Querol Gutiérrez, Francisco Javier Rodríguez de Rivera, Carolina Colomer Font, Enrique Noé Sebastián, Mª Dolores Navarro Pérez, Alan Juárez Belaunde, Joan Ferri Campos, Teresa Cristina Guijarro Castro

Abstract readPractice GuidelineEnglish Abstract
In one paragraph

Guideline in Revista espanola de salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mónica Povedano PandésGrupo de Estudio de Enfermedades Neuromusculares de la Sociedad Española de Neurología. Barcelona. España.
Ricard Rojas GarcíaGrupo de Estudio de Enfermedades Neuromusculares de la Sociedad Española de Neurología. Barcelona. España.
Luis Querol GutiérrezGrupo de Estudio de Enfermedades Neuromusculares de la Sociedad Española de Neurología. Barcelona. España.
Francisco Javier Rodríguez de RiveraGrupo de Estudio de Enfermedades Neuromusculares de la Sociedad Española de Neurología. Barcelona. España.
Carolina Colomer FontSociedad Española de Neurorrehabilitación (SENR). España.
Enrique Noé SebastiánSociedad Española de Neurorrehabilitación (SENR). España.
Mª Dolores Navarro PérezSociedad Española de Neurorrehabilitación (SENR). España.
Alan Juárez BelaundeSociedad Española de Neurorrehabilitación (SENR). España.
Joan Ferri CamposSociedad Española de Neurorrehabilitación (SENR). España.
Teresa Cristina Guijarro CastroSubdirección General de Calidad Asistencial. Ministerio de Sanidad. Madrid. España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postpolio syndrome (PPS), which affects 20% to 50% of patients decades after initial poliovirus infection, poses a significant clinical challenge due to its unknown etiology and lack of pathogenic treatment. The main current theories point to degenerative processes secondary to the initial infection as the basis of its pathogenesis. Our guide addresses this complex landscape, providing a structured, evidence-based approach to the management of these sequelae. We emphasize the importance of: A personalized comprehensive evaluation; The development of multidisciplinary programs specifically designed to maximize functionality; Preventing complications and improving the quality of life of patients. We propose that these interventions be carried out under the supervision of an interdisciplinary team of specialists, who will use validated tools and personalized strategies based on the individual clinical characteristics of each patient. This approach ensures optimal functional benefit, aligned with current principles of evidence-based clinical practice.

Indexed as

Postpoliomyelitis SyndromeHumansDiagnosisPost-polio syndromeRecommendations guideSpain

Identifiers

PMID40530649
PMCPMC12175752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.